IRS1 and neoplasm: In addition, NE was shown to stimulate tumor cell proliferation by degrading the insulin receptor substrate-1 (IRS-1), resulting in an increased interaction between phosphatidylinositol kinase-3 (PI3K) and platelet-derived growth factor receptor (PDGFR) [12].